
Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis
Author(s) -
Alejandro Piscoya,
Angela Parra del Riego,
Renato Cerna-Viacava,
Jonathon Rocco,
Yuani M. Roman,
Ángel A. Escobedo,
Vinay Pasupuleti,
Christopher White,
Adrian V. Hernández
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0269368
Subject(s) - tocilizumab , covid-19 , meta analysis , medicine , medline , bioinformatics , virology , biology , rheumatoid arthritis , disease , biochemistry , outbreak , infectious disease (medical specialty)